Evidence map›Paper›PMID 32380514›Full record

ArticlePloS one2020

Diversity in kinetics correlated with structure in nano body-stabilized LacY.

Hemant Kumar, Janet Finer-Moore, Irina Smirnova, Vladimir Kasho, Els Pardon, Jan Steyaert, H Ronald Kaback, Robert M Stroud

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Function Trumps Form in Two Sugar Symporters,International journal of molecular sciences · 2021
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Hemant KumarDepartment of Biochemistry and Biophysics, University of California, San Francisco, California, United States of America.
Janet Finer-MooreDepartment of Biochemistry and Biophysics, University of California, San Francisco, California, United States of America.
Irina SmirnovaDepartment of Physiology, University of California, Los Angeles, California, United States of America.
Vladimir KashoDepartment of Physiology, University of California, Los Angeles, California, United States of America.
Els PardonVIB-VUB Center for Structural Biology, VIB, Brussels, Belgium.
Jan SteyaertVIB-VUB Center for Structural Biology, VIB, Brussels, Belgium.ORCID 0000-0002-3825-874X
H Ronald KabackDepartment of Physiology, University of California, Los Angeles, California, United States of America.
Robert M StroudDepartment of Biochemistry and Biophysics, University of California, San Francisco, California, United States of America.ORCID 0000-0003-2083-5665
University of California, Los Angeles · USUniversity of California, San Francisco · USVrije Universiteit Brussel · BE

Funding

STRUCTURE/FUNCTION OF PROTEINS AT MOLECULAR LEVELR01GM024485 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STROUD, ROBERT M · 1985 to 2024
$7.5M
Molecular Basis for Transmembrane Conduction & SignalingR37GM024485 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STROUD, ROBERT M · 2007 to 2016
$4.7M
Dynamics of the Lactose Permease of Escherichia ColiR01GM120043 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WRIGHT, ERNEST M · 2016 to 2019
$1.8M
NIGMS NIH HHS R01 GM024485NIGMS NIH HHS R01 GM120043NIGMS NIH HHS R37 GM024485
6 · The paper itself

Abstract

The structure of lactose permease, stabilized in a periplasmic open conformation by two Gly to Trp replacements (LacYww) and complexed with a nanobody directed against this conformation, provides the highest resolution structure of the symporter. The nanobody binds in a different manner than two other nanobodies made against the same mutant, which also bind to the same general region on the periplasmic side. This region of the protein may represent an immune hotspot. The CDR3 loop of the nanobody is held by hydrogen bonds in a conformation that partially blocks access to the substrate-binding site. As a result, kon and koff for galactoside binding to either LacY or the double mutant complexed with the nanobody are lower than for the other two LacY/nanobody complexes though the Kd values are similar, reflecting the fact that the nanobodies rigidify structures along the pathway. While the wild-type LacY/nanobody complex clearly stabilizes a similar 'extracellular open' conformation in solution, judged by binding kinetics, the complex with wild-type LacY did not yet crystallize, suggesting the nanobody does not bind strongly enough to shift the equilibrium to stabilize a periplasmic side-open conformation suitable for crystallization. However, the similarity of the galactoside binding kinetics for the nanobody-bound complexes with wild type LacY and with LacYWW indicates that they have similar structures, showing that the reported co-structures reliably show nanobody interactions with LacY.

Indexed as

Amino Acid SubstitutionAntigen-Antibody ReactionsBinding SitesCrystallography, X-RayEscherichia coli ProteinsGalactoseGlycineHydrogen BondingKineticsModels, MolecularMonosaccharide Transport ProteinsMutation, MissensePoint MutationProtein BindingProtein ConformationProtein StabilityEscherichia coli ProteinsGalactoseGlycineLacY protein, E coliMonosaccharide Transport ProteinsSingle-Domain AntibodiesSymportersthiodigalactosideThiogalactosidesTryptophan

Identifiers

PMID32380514
PMCPMC7205474
OpenAlexW3021781153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.